Heterogeneity of factor IX BM difference of cleavage sites by factor XIa and Ca2+in factor IX Kashihara, Factor IX Nagoya and Factor IX Niigata-Reference-Cited by-同舟云学术

Heterogeneity of factor IX BM difference of cleavage sites by factor XIa and Ca2+in factor IX Kashihara, Factor IX Nagoya and Factor IX Niigata

Published:1986-06 Issue:5 Volume:42 Page:595-604
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Yoshioka Akira,Ohkubo Yoshiaki,Nishimura Takuya,Tanaka Ichiro,FuKui Hiromu,Ogata Kanji,Kamiya Tadashi,Takahashi Hoyu

Publisher

Elsevier BV

Subject

Hematology

Reference18 articles.

1. Haemophilia B : A new type of factor-IX deficiency;Hougie;Lancet,1967

2. Purification and properties of an abnormal blood coagulation factor IX (Factor IXBm)/Kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor;Østerud;Thromb. Haemostas.,1981

3. Factor IX Deventer-Evidence for the heterogeneity of hemophilia BM;Bertina;Thromb. Haemostas.,1982

4. Partial proteglytic susceptibility to contact activation in hemophilia B+ with slightly prolonged bovine brain prothrombin time;Fukui;J. Nara Med. Ass.,1981

5. A study of the coagulation defect in hemophilia and in jaundice;Quick;Amer. J. Med. Sci.,1935

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. My translational research of hemophilia B and factor IX;Japanese Journal of Thrombosis and Hemostasis;2012

2. Comparison of the behavior of normal factor IX and the factor IX BM variant hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources;American Journal of Hematology;1993-07

3. Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.;Journal of Biological Chemistry;1990-07

4. A mutation adjacent to the beta cleavage site of factor IX (valine 182 to leucine) results in mild haemophilia Bm;British Journal of Haematology;1990-06

5. Factor IX Kawachinagano: impaired function of the Gla-domain caused by attached propeptide region due to substitution of arginine by glutamine at position −4;British Journal of Haematology;1989-06